Did Starbucks Just Give Investors Nearly 2.9 Billion Reasons to Buy Its Stock?

Starbucks raised its quarterly dividend by $0.01 to $0.63 per share, maintaining its annual increase streak since 2010; the new annual payout is $2.52 per share, with a yield just under 2.5%. Fiscal Q3 revenue fell slightly more than 1% year over year to $9.3 billion, while global comparable-store sales rose nearly 8% and operating income increased 5% to $980 million; reported net income also benefited from the China stake sale and tariff refunds. The article views the operating trends positively but says a forward P/E above 32 makes the stock too expensive to buy.

Analysis

The key underwriting question is whether the comparable-sales rebound converts into durable, cash-backed earnings growth—not whether the dividend streak continues. Faster service and lower pickup congestion could improve throughput and labor productivity, but the next proof point is sustained transaction growth without discounting or deteriorating customer experience. A sales mix shift toward licensed China operations may also support margins while reducing reported revenue; investors should track recurring operating profit and cash generation rather than GAAP net income, which the article says was affected by the stake sale and tariff refunds.

Near term, the dividend increase is a weak signal of confidence, not evidence that the payout is accelerating. With annual distributions near $2.9 billion, a reversal in operating momentum would make capital returns less flexible. Over the next 1–3 months, earnings commentary on North American traffic, labor costs, and China royalties is more consequential than the raise. Over 6–18 months, the turnaround thesis depends on execution scaling across stores and translating into margins and free cash flow.

The contrarian risk is that investors may treat a recovery in comps as a renewed growth trajectory while the company is still repairing execution. Conversely, the revenue decline may overstate weakness if licensed China economics prove more profitable on a recurring basis. The article’s valuation estimate is not independently verified; confirm current valuation and cash-flow data before sizing risk.

Key Decisions for Investors

• Avoid buying SBUX solely for the dividend streak. Treat the next earnings report as a confirmation event: require evidence that sales gains are supported by traffic and recurring operating improvement, not just favorable comparisons or mix.
• For a cautious relative-value expression, consider underweighting SBUX versus a diversified consumer-discretionary benchmark rather than initiating an outright short. The setup is valuation-sensitive and could squeeze if turnaround execution continues; size modestly pending verified valuation and consensus data.
• Track North American transaction growth, store-level labor/productivity commentary, recurring operating income, and free cash flow alongside China JV royalty economics. Weak traffic, margin deterioration, or a downward guidance revision would falsify the recovery case; sustained gains in these metrics would argue against the underweight.
• Reassess after earnings and over the following 1–3 months. Verify the current forward multiple, dividend coverage by free cash flow, and whether China-related revenue and profit are reported on comparable bases before adding exposure.